Supplemental Figures
. Determination of the spectral overlap, origin, and dynamic range of NAD(P)H and FAD fluorescence emission during the redox imaging procedure. (A-C) Determining the spectral overlap of the endogenous fluorophores and cancer therapeutics to ensure correct image analysis. Emission intensity of (A) pure NADH, (B) pure FAD, and (C) BPD solutions at 440 ± 20nm (blue) and 520 ± 20nm (green) upon 750nm excitation. (D) Fluorescence emission of NAD(P)H and FAD is mainly detected in perinuclear foci in both MIA PaCa-2 PDAC cells (left panels) and cancer associated fibroblasts (CAF, right panels). Scalebar = 20µ m. (E) Histograms depicting the tissue-derived emission intensities within the dynamic range of the detector. Histograms depict fluorescence intensities measured in 2D culture, 3D suspended spheroids, 3D adherent spheroids, and ex-vivo cryopreserved tissues. 
